Malaria vaccine showed 100% long-term protection in humans

0
3
views

Such a result, scientists recorded for the first time. Until now, none of the candidates for the vaccine showed such a long defense. Although clinical studies are still ongoing, the authors believe that their drug will become an effective means for protecting travelers and residents of endemic in the malaria of the regions.

PFSPZ vaccine has developed an American biotechnology company Sanaria. Currently, the first phase of clinical trials is completed and the phase continues 2. PFSPZ was administered to participants in combination with one of the antimalarial preparations — pyrimethanmic or chlorochin. Together with the latter, 100% infection protection was recorded for three months. Results of research

Malaria causes PLASMODIUM pathogen. The PFSPZ vaccine contains one of its forms — purified Plasmodium Falciparum sprouts, which through blood penetrate into the liver and cause infection. In addition to the vaccine, scientists have appointed volunteer reception or pyrimetamine that kills the causative agent in the liver, or chlorohin operating in the bloodstream.

Three months after vaccination and drug intake, participants were injected with a pathogen through blood.

With low dosages, protection was weak. So, only two of nine volunteers (taken pyrimetamine) were protected from malaria. The highest dosage has been protected from 77.8% to 87.5%, depending on the pathogen strain.

The best result was the combination of PFSPZ with chlorochin. All six participants showed 100% protection against malaria for at least three months after vaccination.

In their opinion, the vaccine can be a promising means for both residents of endemic districts and for tourists. Every year more than 220 million people are sick and about 400 thousand die from infection.

Recently another group of American researchers also


We tell about the most interesting news and technologies — from the upcoming total automation to alternative energy, from artificial intelligence to the future medicine.

Hayk +